Ameritas Investment Partners, Inc. Cyma Bay Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $24,906 - $48,254	1,972 Added 20.23%	11,718 $276,000
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $17,875 - $29,002	1,646 Added 20.32%	9,746 $145,000
Q2 2023 Aug 11, 2023	BUY	$7.47 - $10.95 $60,507 - $88,695	8,100 New	8,100 $88,000
Q2 2022 Aug 12, 2022	SELL	$1.72 - $3.39 $10,247 - $20,197	-5,958 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $5,959 - $9,391	1,040 Added 21.15%	5,958 $34,000
Q2 2018 Aug 13, 2018	BUY	$10.66 - $14.38 $52,425 - $70,720	4,918 New	4,918 $66,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.